MIRA INFORM
REPORT
|
Report Date : |
24.11.2011 |
IDENTIFICATION DETAILS
|
Name : |
OPSONIN PHARMA LIMITED |
|
|
|
|
Registered Office : |
Opsonin Complex (5th Floor), 30
New Eskaton Road, Dhaka-1000 |
|
|
|
|
Country : |
Bangladesh |
|
|
|
|
Date of Incorporation : |
10.03.1976 |
|
|
|
|
Com. Reg. No.: |
C-4741 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturing, Selling and Exporting of all types of drugs and
medicine |
|
|
|
|
No. of Employees : |
2,600 Persons |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 25,000.00 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Bangladesh |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
COMPANY DETAILS
|
Name |
Opsonin Pharma Limited |
|
Address |
Opsonin Complex (5th Floor), 30 New Eskaton Road, Dhaka-1000 |
|
Country |
Bangladesh |
|
Telephone No |
880-2-9332262, 9337055, 9356451, 9356533 |
|
Fax No |
880-2-8329050 |
|
E-Mail |
|
|
Website |
|
|
Established |
1956 (As Opsonin
Chemical Industries) |
|
Company Registration No |
C-4741 |
|
Registration date |
10th
March 1976 |
|
Legal Status |
Private Limited |
|
Issuing Authority |
The Registrar of Joint Stock Companies & Firms, Dhaka |
|
Business Type |
Manufacturer, Seller & Exporter |
|
Status |
Satisfactory |
|
Payment Behavior |
No complaints have been heard regarding payments from local
suppliers or banks. |
LOCATIONS
|
Head Office |
Opsonin Complex (5th Floor), 30 New Eskaton Road, Dhaka-1000 |
|
Telephone No |
880-2-9332262, 9337055, 9356451, 9356533 |
|
Fax No |
880-2-8329050 |
|
E-Mail |
|
|
Website |
|
|
Branch |
4 Dhaka 4 Chittagong 4 Sylhet 4 Mymensingh 4 Rangpur 4 Comilla 4 Borga 4 Khulna 4 Pabna 4 Barishal |
|
Factory |
Bogra
Road, Barishal |
|
Factory Telephone No |
N/A |
|
Factory Fax No |
N/A |
|
Warehouse |
Bogra Road,
Barishal |
DIRECTORS
|
Name |
Capt. M. A. Bashar Khan |
|
Designation |
Chairman |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. Abdur Rouf
Khan |
|
Designation |
Managing
Director |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. Abdur Rakib Khan |
|
Designation |
Director |
|
Nationality |
Bangladeshi |
SHAREHOLDERS
|
Name |
Capt. M. A. Bashar
Khan |
|
Share Percent |
40% |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. Abdur Rouf
Khan |
|
Share Percent |
40% |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. Abdur Rakib
Khan |
|
Share Percent |
20% |
|
Nationality |
Bangladeshi |
BUSINESS DETAILS
|
Line of Business |
Manufacturer, Seller & Exporter |
|
Items Dealing In |
Drugs &
Medicine |
|
Terms of Purchase |
Local: Cash or Credit Import: Against L/C |
|
Terms of Sale |
Local: Cash or Credit Export: Against L/C |
BANKERS
|
Name |
EXIM Bank
Limited |
|
Branch |
Eskaton Road
Branch |
|
Address |
Eskaton Road, Dhaka |
|
SWIFT |
N/A |
|
|
|
|
Name |
Uttara Bank
Limited |
|
Branch |
Bangabandhu
Avenue Branch |
|
Address |
Bangabandhu Avenue, Dhaka |
|
SWIFT |
N/A |
FINANCIAL INFORMATION
|
Year |
2010 |
2009 |
2008 |
|
Investment |
Tk.207 million |
Tk.205 million |
Tk.205 million |
|
Turnover |
Tk.4 billion |
Tk.3.9 billion |
Tk.3.5 billion |
|
Liability |
Tk.130 million |
Tk.131.7 million |
Tk.132 million |
|
Assets |
Tk.878 million |
Tk.875 million |
Tk.875 million |
* The subject has flatly refused to reveal any information. Whatever given here is collected un-officially and as such its authenticity could not be verified.
CAPITAL STRUCTURE
|
Authorized
Capital |
Tk.500 million |
|
Paid Up Capital |
Tk.50 million |
|
Each Share Value |
Tk.100.00 |
EXCHANGE RATE
|
Currency |
Unit |
Bangladeshi Taka (BDT) |
|
Great Britain Pound |
1 |
118.4520 |
|
U.S Dollar |
1 |
74.4700 |
|
European Euro |
1 |
104.5038 |
ADVERSE DATA MONITORING
|
Dishonored
Checks |
No Found |
|
Debt |
No Records Found |
|
Litigation |
No Records Found |
|
Performance
Defaults |
No Records Found |
|
Adverse Press
Coverage |
No Records Found |
|
Money Laundering |
No Records Found |
MAXIMUM RECOMMENDED CREDIT
|
Amount |
Based On` |
|
US$ 25,000.00 |
90 Days |
GENERAL INFORMATION
|
Employees |
2,600 |
|
Office Area (Sq.
Ft) |
5,800 sq.ft (own) |
|
Factory Area
(Sq. Ft) |
2.5 acres of lands (own) |
|
Warehouse Area
(Sq. Ft) |
8,950 sq.ft.(own) |
|
Range of
Products |
4 Ace
Inhibitors 4 Amino
glycosides 4 Analgesic, Antipyretic &
NSAIDs 4 Angiotensin Receptor Blokers 4 Antacids 4 Antheimintics 4
Anti-Parkinsonism Agents 4
Antiasthmatics 4
Antidepressaants 4
Antidiabetics 4
Antihistaminics 4
Antidiarrhorea 4 Antiepileptic 4
Antifungal 4
Antihaemorrhoidals 4
Antimalarials 4
Antimetics & Gastroprokinetics 4
Antiplatelets 4
Antiprotozoals 4
Antipsychotics 4
Antiseptic & Disinfectants 4
Antispasmodics 4
Antiulcerants 4
Antivertigo Agents 4
Anxiolytics 4 Beta
Blokers 4 Calcium
channel bloker 4 Cardiac
Glycoside 4 Central
vasodialator 4
Cephalosporins 4
Cholagogues & Hepatic Protectors 4
Combination & others 4
Corticosteroids 4 Cough
Expectorants & Suppressants 4
Digestive Enzyme 4
Diuretics 4 H2
Receptor Blokers 4 Hypnotic 4
Laxatives 4 Lipid
Lowering Agents 4
Macrolides 4 Muscle
Relaxant 4
Narcotic Analgesics 4
Neurotonics 4 Other
B-lactam except Penicillin, Cephalosproin 4
Penicillins 4
Prolactin Inhibitor 4 Proton
Pump0 Inhibitors 4
Psycholeptic antidepressants 4 Quinolones 4
Scabicide 4 Steriod 4
Tetracyclines 4 Topical
Antibacterials 4
Uterotonics 4 Vitamins, Minerals &
Hematinics |
|
Export Market |
4 Myanmar 4 Mauritius 4 Nepal 4 Pakistan 4 Philippines 4 Sri Lanka 4 Togo 4 Vietnam 4 Yemen |
|
Raw Materials
From |
4 USA 4 EEC
Countries 4
Malaysia 4 Korea 4 China 4
Singapore 4
Thailand 4
Australia 4 Denmark 4 Hong Kong |
|
Major Clients |
4 Medical College 4 Private Clinic 4 Local Markets |
|
Certifications |
4 ISO-9001 |
|
Group Name |
4 Opsonin Group |
|
Subsidiaries /
Affiliates |
4 Opso
Saline 4 Opsonin Bulk Drugs Limited 4 Opsonin Consumer Products Limited |
|
Member |
4 Bangladesh Aushad Manufacturers
Association, Dhaka 4 Dhaka Chamber of Commerce &
Industries, Dhaka |
COMMENTS
The subject is a private limited company engaged in manufacturing,
selling and exporting of all types of drugs and medicine to overseas countries
and in local market. The subject was originally established as a partnership
company in 1956. Later in 1976 it was registered as a Private limited company
with the name Opsonin Chemical Industries Limited. In 2005 the company changed
its name to Opsonin Pharma Limited. The subject is a concern of Opsonin Group.
The subject is a one of the leading pharmaceutical products manufacturer in
Bangladesh.
The directors are well conversant in their line of trade and
they are also experienced businessman. They are financially solvent and good at
their business commitment, it reported.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.10 |
|
UK Pound |
1 |
Rs.81.30 |
|
Euro |
1 |
Rs.70.07 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.